---
title: Clinical Use Guide for Healthcare Providers
description: Evidence-based guidance for healthcare providers using ADHD Research Database findings in clinical practice for adult ADHD treatment
audience: healthcare
difficulty: intermediate
---

# Clinical Use Guide for Healthcare Providers

This guide provides healthcare providers with evidence-based guidance for integrating ADHD Research Database findings into clinical decision-making for adult patients. It covers evidence interpretation, treatment planning support, assessment tool clinical utility, and professional considerations.

## Table of Contents

1. [Intended Use Statement](#intended-use-statement)
2. [Target Population](#target-population)
3. [Evidence Level Interpretation for Clinical Decisions](#evidence-level-interpretation-for-clinical-decisions)
4. [Quality Indicators](#quality-indicators)
5. [Clinical Decision Flow](#clinical-decision-flow)
6. [Assessment Tool Clinical Utility](#assessment-tool-clinical-utility)
7. [Using Research Findings for Treatment Planning](#using-research-findings-for-treatment-planning)
8. [Integrating Database Findings with Patient Care](#integrating-database-findings-with-patient-care)
9. [Workplace-Specific Considerations](#workplace-specific-considerations)
10. [Limitations and Disclaimers](#limitations-and-disclaimers)
11. [Referral Resources](#referral-resources)
12. [Professional Responsibility Notes](#professional-responsibility-notes)
13. [Summary](#summary)

---

## Intended Use Statement

### Purpose

The ADHD Research Database is designed as a **clinical decision support resource** to assist healthcare providers in:

- Accessing peer-reviewed evidence for adult ADHD interventions
- Understanding the strength of evidence supporting various treatment approaches
- Identifying research relevant to professional adult patients (25-65)
- Supporting treatment discussions with patients using evidence summaries
- Tracking emerging research in workplace-focused ADHD interventions

### This Database Is

- A curated repository of 281+ peer-reviewed research findings
- A reference tool for evidence-based treatment planning discussions
- A source of validated assessment scoring information (ASRS, AAQoL)
- A compendium of intervention protocols with evidence ratings

### This Database Is NOT

- A diagnostic tool or diagnostic decision system
- A substitute for clinical judgment or professional evaluation
- A prescribing guide or medication recommendation system
- A replacement for comprehensive clinical assessment
- A source of individualized treatment recommendations

```
+------------------------------------------------------------------+
|                    CLINICAL USE FRAMEWORK                          |
+------------------------------------------------------------------+
|                                                                    |
|   APPROPRIATE USE                 |   INAPPROPRIATE USE            |
|   --------------------------------|-------------------------------  |
|   - Literature reference          |   - Standalone diagnosis        |
|   - Treatment planning support    |   - Prescribing without eval    |
|   - Evidence discussions          |   - Replacing clinical judgment |
|   - Outcome measure selection     |   - Patient self-treatment      |
|   - Protocol reference            |   - Bypassing specialist care   |
|                                                                    |
+------------------------------------------------------------------+
```

---

## Target Population

### Primary Focus: Professional Adult Males (25-65)

The research in this database is curated specifically for relevance to:

**Demographics:**
- Adults aged 25-65 years
- Primarily male populations (reflecting research availability)
- Professional and occupational settings
- Employed or career-oriented individuals

**Clinical Presentations:**
- Diagnosed adult ADHD (all presentations)
- Late-diagnosed individuals
- High-functioning presentations with occupational challenges
- Comorbid presentations common in professional populations

**Occupational Contexts:**
- Knowledge workers and professionals
- Executive and management roles
- Technical and specialized positions
- Self-employed and entrepreneurial individuals

### Clinical Relevance Considerations

When applying database findings, consider:

| Factor | Clinical Consideration |
|--------|------------------------|
| Age at diagnosis | Late diagnosis may indicate masking/coping mechanisms |
| Occupational demands | High executive function requirements in professional roles |
| Presentation type | Inattentive presentation often predominates in adults |
| Comorbidities | Anxiety, depression common in professional populations |
| Prior treatment | Many may have self-managed without formal diagnosis |

---

## Evidence Level Interpretation for Clinical Decisions

### Evidence Hierarchy for Clinical Practice

The database uses a modified Oxford Centre for Evidence-Based Medicine (OCEBM) hierarchy adapted for ADHD treatment research.

```
+------------------------------------------------------------------+
|                    EVIDENCE LEVEL HIERARCHY                        |
+------------------------------------------------------------------+
|                                                                    |
|   LEVEL 1A  |  Systematic review/meta-analysis of RCTs            |
|   [Strong]  |  Clinical Confidence: HIGH                           |
|             |  Action: Can inform standard treatment protocols     |
|             |                                                       |
|   LEVEL 1B  |  Individual well-designed RCT                        |
|   [Strong]  |  Clinical Confidence: HIGH                           |
|             |  Action: Strong support for intervention choice      |
|             |                                                       |
|   LEVEL 2A  |  Systematic review of cohort studies                 |
|   [Moderate]|  Clinical Confidence: MODERATE                       |
|             |  Action: Consider with patient-specific factors      |
|             |                                                       |
|   LEVEL 2B  |  Individual cohort study or low-quality RCT          |
|   [Moderate]|  Clinical Confidence: MODERATE                       |
|             |  Action: Supportive evidence, not standalone         |
|             |                                                       |
|   LEVEL 3A  |  Systematic review of case-control studies           |
|   [Limited] |  Clinical Confidence: LOW-MODERATE                   |
|             |  Action: Hypothesis-generating, caution advised      |
|             |                                                       |
|   LEVEL 3B  |  Individual case-control study                       |
|   [Limited] |  Clinical Confidence: LOW                            |
|             |  Action: Preliminary evidence only                   |
|             |                                                       |
|   LEVEL 4   |  Case series, poor-quality studies                   |
|   [Very Low]|  Clinical Confidence: VERY LOW                       |
|             |  Action: Clinical experience supplement              |
|             |                                                       |
|   LEVEL 5   |  Expert opinion                                      |
|   [Expert]  |  Clinical Confidence: CONTEXTUAL                     |
|             |  Action: When higher evidence unavailable            |
|                                                                    |
+------------------------------------------------------------------+
```

### Clinical Decision Matrix by Evidence Level

| Evidence Level | Treatment Initiation | Patient Discussion | Documentation |
|----------------|---------------------|-------------------|---------------|
| 1A | Standard of care consideration | "Strong evidence supports..." | Reference systematic reviews |
| 1B | Well-supported choice | "Clinical trials demonstrate..." | Cite specific RCTs |
| 2A | Reasonable option | "Research suggests..." | Note observational nature |
| 2B | Consider with caveats | "Some studies indicate..." | Document limited evidence |
| 3-4 | Individualized decision | "Limited evidence suggests..." | Document clinical rationale |
| 5 | Expert guidance when needed | "Expert consensus recommends..." | Note absence of trials |

### Applying Evidence Levels in Practice

**High-Confidence Decisions (Level 1A-1B):**
- Stimulant medication efficacy for core symptoms
- Cognitive behavioral therapy for functional outcomes
- Combination treatment approaches

**Moderate-Confidence Decisions (Level 2A-2B):**
- Specific workplace accommodation effectiveness
- Long-term occupational outcomes
- Non-stimulant medication comparative effectiveness

**Preliminary Evidence (Level 3-5):**
- Novel interventions (neurofeedback, supplements)
- Specific professional population outcomes
- Emerging digital therapeutics

---

## Quality Indicators

### Risk of Bias Assessment

Studies in the database include risk of bias ratings using standardized assessment tools.

#### Risk of Bias Categories

| Level | Definition | Clinical Interpretation |
|-------|------------|------------------------|
| **LOW** | Minimal methodological concerns | High confidence in findings |
| **MODERATE** | Some limitations present | Consider findings with awareness of limitations |
| **HIGH** | Significant methodological flaws | Use findings cautiously, seek corroboration |

#### Common Bias Sources in ADHD Research

- **Selection bias**: Non-representative patient samples
- **Performance bias**: Unblinded treatment allocation
- **Detection bias**: Unblinded outcome assessment
- **Attrition bias**: Differential dropout between groups
- **Reporting bias**: Selective outcome reporting

### GRADE Certainty Ratings

The GRADE (Grading of Recommendations Assessment, Development and Evaluation) system provides overall certainty ratings for bodies of evidence.

```
+------------------------------------------------------------------+
|                    GRADE CERTAINTY RATINGS                         |
+------------------------------------------------------------------+
|                                                                    |
|   HIGH                                                             |
|   +------------------------------------------------------------+  |
|   | Very confident true effect lies close to the estimate       |  |
|   | Clinical Action: Implement with confidence                  |  |
|   +------------------------------------------------------------+  |
|                                                                    |
|   MODERATE                                                         |
|   +------------------------------------------------------------+  |
|   | Moderately confident; true effect likely close to estimate  |  |
|   | Clinical Action: Implement with monitoring                  |  |
|   +------------------------------------------------------------+  |
|                                                                    |
|   LOW                                                              |
|   +------------------------------------------------------------+  |
|   | Limited confidence; true effect may differ substantially    |  |
|   | Clinical Action: Consider carefully, discuss with patient   |  |
|   +------------------------------------------------------------+  |
|                                                                    |
|   VERY LOW                                                         |
|   +------------------------------------------------------------+  |
|   | Very little confidence; true effect likely differs          |  |
|   | Clinical Action: Only when alternatives unavailable         |  |
|   +------------------------------------------------------------+  |
|                                                                    |
+------------------------------------------------------------------+
```

### Interpreting Effect Sizes Clinically

| Measure | Small | Medium | Large | Clinical Significance Threshold |
|---------|-------|--------|-------|--------------------------------|
| Cohen's d | 0.2 | 0.5 | 0.8 | d >= 0.5 often clinically meaningful |
| Odds Ratio | 1.5 | 2.0 | 3.0 | OR >= 2.0 typically clinically relevant |
| NNT | >10 | 5-10 | <5 | NNT <= 5 indicates strong effect |
| Correlation r | 0.1 | 0.3 | 0.5 | r >= 0.3 clinically notable |

---

## Clinical Decision Flow

The following diagram illustrates how database resources integrate with clinical ADHD evaluation and treatment planning.

```
+------------------------------------------------------------------+
|                    CLINICAL DECISION FLOW                          |
|              (Database Integration Points Marked *)                |
+------------------------------------------------------------------+
                              |
                              v
                    +-------------------+
                    |  Patient Presents |
                    |  with Concerns    |
                    +--------+----------+
                             |
                             v
               +---------------------------+
               |   Initial Clinical        |
               |   Assessment              |
               |   - History taking        |
               |   - Symptom review        |
               |   - Functional impact     |
               +------------+--------------+
                            |
                            v
         +----------------------------------+
         |   * Screening Tools              |
         |   ASRS (symptom screening)       |
         |   AAQoL (functional impact)      |
         |   [Database: Assessment info]    |
         +---------------+------------------+
                         |
           +-------------+-------------+
           |                           |
           v                           v
+-------------------+       +---------------------+
| Below Threshold   |       | Above Threshold     |
| - Monitor         |       | - Comprehensive     |
| - Reassess PRN    |       |   evaluation        |
+-------------------+       +----------+----------+
                                       |
                                       v
                   +-----------------------------------+
                   |   Comprehensive Diagnostic        |
                   |   Evaluation                      |
                   |   - Clinical interview            |
                   |   - Collateral information        |
                   |   - Differential diagnosis        |
                   |   - Comorbidity assessment        |
                   +----------------+------------------+
                                    |
              +---------------------+---------------------+
              |                                           |
              v                                           v
    +-------------------+                     +---------------------+
    | ADHD Diagnosis    |                     | Alternative/        |
    | Confirmed         |                     | Comorbid Diagnosis  |
    +--------+----------+                     +---------------------+
             |
             v
+----------------------------------+
|   * Treatment Planning           |
|   [Database: Evidence search]    |
|   - Review evidence levels       |
|   - Consider patient factors     |
|   - Discuss options with patient |
+---------------+------------------+
                |
    +-----------+-----------+
    |           |           |
    v           v           v
+-------+  +--------+  +---------+
| Pharm |  | Psych  |  | Combo   |
| Tx    |  | Tx     |  | Tx      |
+---+---+  +---+----+  +----+----+
    |          |            |
    +----------+------------+
               |
               v
+----------------------------------+
|   * Outcome Monitoring           |
|   [Database: Outcome measures]   |
|   - Symptom tracking (ASRS)      |
|   - Functional impact (AAQoL)    |
|   - Workplace outcomes           |
+---------------+------------------+
                |
                v
+----------------------------------+
|   Treatment Adjustment           |
|   - Response assessment          |
|   - Side effect management       |
|   - * Evidence-based             |
|     modifications                |
+----------------------------------+
```

---

## Assessment Tool Clinical Utility

### ASRS (Adult ADHD Self-Report Scale)

#### Clinical Application

The ASRS is a validated screening instrument, NOT a diagnostic tool. Use it for:

| Purpose | Appropriate | Inappropriate |
|---------|-------------|---------------|
| Initial screening | Yes | - |
| Treatment monitoring | Yes | - |
| Symptom tracking over time | Yes | - |
| Standalone diagnosis | - | No |
| Medication dosing decisions | - | No |

#### Interpreting ASRS in Clinical Practice

**ASRS-6 Screener (6 items):**

| Score | Clinical Interpretation | Recommended Action |
|-------|------------------------|-------------------|
| 0-13 | Low symptom endorsement | Further evaluation if clinical suspicion persists |
| 14-17 | Moderate symptom endorsement | Comprehensive evaluation indicated |
| 18-24 | High symptom endorsement | Comprehensive evaluation strongly indicated |

**Full ASRS (18 items):**

| Score | Clinical Interpretation | Recommended Action |
|-------|------------------------|-------------------|
| 0-16 | Low symptom burden | Monitor, reassess if concerns persist |
| 17-23 | Moderate symptom burden | Comprehensive evaluation indicated |
| 24+ | High symptom burden | Comprehensive evaluation essential |

#### ASRS Psychometric Considerations

- **Sensitivity**: 68.7% - 91.4% (cutoff dependent)
- **Specificity**: 63.0% - 96.0%
- **PPV**: Varies significantly by base rate in population
- **Clinical Note**: Higher false positive rate in clinical populations with comorbidities

### AAQoL (Adult ADHD Quality of Life Scale)

#### Clinical Application

The AAQoL measures functional impact across life domains, useful for:

| Purpose | Utility |
|---------|---------|
| Baseline functional assessment | High |
| Treatment response monitoring | High |
| Identifying priority treatment targets | High |
| Communicating impact to patients | Moderate |
| Justifying treatment intensity | Moderate |

#### AAQoL Domain Interpretation

| Domain | Low Score Indicates | Clinical Focus |
|--------|---------------------|----------------|
| **Life Productivity** | Occupational impairment | Workplace interventions, accommodations |
| **Psychological Health** | Emotional dysregulation | CBT, emotional regulation support |
| **Life Outlook** | Motivational difficulties | Goal-setting, coaching interventions |
| **Relationships** | Interpersonal challenges | Social skills, couples therapy |

#### Treatment Target Identification

```
AAQoL Domain Scores -> Treatment Target Matrix
+------------------------------------------------------------------+
|                                                                    |
|   Domain Score < 40        |    Intervention Priority              |
|   -------------------------|--------------------------------------  |
|   Life Productivity        |    Workplace accommodations, coaching |
|   Psychological Health     |    CBT, ADHD-focused therapy          |
|   Life Outlook             |    Motivational interviewing, goals   |
|   Relationships            |    Interpersonal skills, family Tx    |
|                                                                    |
+------------------------------------------------------------------+
```

---

## Using Research Findings for Treatment Planning

### Evidence-Based Treatment Selection

#### Step 1: Identify Treatment Goals

Work with the patient to establish:
- Primary symptom targets (inattention, hyperactivity-impulsivity)
- Functional outcome priorities (work performance, relationships)
- Patient preferences and constraints

#### Step 2: Search Database for Relevant Evidence

Use the Research Explorer to:
- Search by treatment type (pharmacological, psychological, behavioral)
- Filter by evidence level (prioritize Level 1A-1B for primary recommendations)
- Filter for workplace focus when occupational outcomes are priority

#### Step 3: Evaluate Evidence Quality

For each relevant study, assess:
- Evidence level (1A-5)
- Risk of bias rating (Low/Moderate/High)
- GRADE certainty (if available)
- Effect size magnitude and clinical significance
- Population comparability to your patient

#### Step 4: Integrate with Patient Factors

Consider:
- Comorbid conditions
- Prior treatment response
- Contraindications
- Patient preferences
- Practical constraints (cost, access, time)

### Treatment Category Evidence Summary

| Treatment Type | Typical Evidence Level | Key Considerations |
|----------------|------------------------|-------------------|
| Stimulant medications | 1A-1B | Strong efficacy evidence; monitor for side effects |
| Non-stimulant medications | 1B-2A | Good evidence; consider for stimulant contraindications |
| CBT for adult ADHD | 1A-1B | Strong evidence for functional outcomes |
| ADHD coaching | 2A-2B | Moderate evidence; especially for professionals |
| Workplace accommodations | 2A-3B | Growing evidence base; individualize |
| Mindfulness-based interventions | 1B-2A | Emerging evidence; adjunctive use |
| Neurofeedback | 2B-3B | Limited evidence; not first-line |

---

## Integrating Database Findings with Patient Care

### Shared Decision-Making Framework

```
+------------------------------------------------------------------+
|              SHARED DECISION-MAKING PROCESS                        |
+------------------------------------------------------------------+
|                                                                    |
|   1. PRESENT EVIDENCE                                              |
|      "Research shows [intervention] has [effect size] on           |
|       [outcome] based on [evidence level] studies."                |
|                                                                    |
|   2. DISCUSS OPTIONS                                               |
|      "Based on the evidence, we could consider..."                 |
|      - Option A: [Treatment] - Evidence Level [X]                  |
|      - Option B: [Treatment] - Evidence Level [Y]                  |
|      - Option C: Combination approach                              |
|                                                                    |
|   3. EXPLORE PREFERENCES                                           |
|      "What matters most to you in treatment?"                      |
|      "What concerns do you have?"                                  |
|                                                                    |
|   4. COLLABORATIVE DECISION                                        |
|      "Based on the evidence and your preferences,                  |
|       let us try [chosen approach] and monitor..."                 |
|                                                                    |
+------------------------------------------------------------------+
```

### Documentation Recommendations

When using database evidence in clinical documentation:

**Include:**
- Evidence level of cited research
- Effect size magnitude when available
- Risk of bias or GRADE rating
- Rationale for treatment selection
- Patient preferences and shared decision-making

**Example Documentation:**
```
Treatment Plan Rationale:
Based on Level 1A evidence supporting stimulant medication for adult
ADHD (effect size d=0.9 for symptom reduction) and patient preference
for medication trial before psychotherapy, initiating methylphenidate
extended-release. Will monitor with ASRS monthly and AAQoL quarterly
to assess symptom response and functional outcomes respectively.
```

### Monitoring Treatment Response

Use database-supported outcome measures:

| Timeframe | Assessment | Purpose |
|-----------|------------|---------|
| Baseline | ASRS (full), AAQoL | Establish pre-treatment levels |
| 4 weeks | ASRS-6, symptom review | Early response assessment |
| 8-12 weeks | ASRS (full), AAQoL | Treatment response evaluation |
| Quarterly | AAQoL, functional review | Long-term outcome monitoring |
| Annually | Comprehensive reassessment | Treatment continuation review |

---

## Workplace-Specific Considerations

### Professional Adult ADHD Presentations

The database emphasizes workplace-relevant research because professional adults often present with:

- High cognitive demands masking ADHD symptoms
- Compensatory strategies developed over time
- Performance inconsistencies rather than consistent impairment
- Executive function deficits manifest in complex task management
- Impairment in unstructured or self-directed work

### Workplace Outcome Measures in Research

When reviewing studies, note workplace-specific outcomes:

| Outcome Category | Measures | Clinical Relevance |
|------------------|----------|-------------------|
| Job performance | Supervisor ratings, productivity metrics | Direct occupational impact |
| Employment stability | Job retention, absence rates | Economic and functional |
| Career advancement | Promotions, salary progression | Long-term outcomes |
| Work satisfaction | Self-reported measures | Quality of life indicator |
| Accommodation effectiveness | Pre/post accommodation outcomes | Intervention planning |

### Accommodation Evidence

The database includes research on workplace accommodations:

- Flexible scheduling arrangements
- Environmental modifications
- Task structure supports
- Technology assistive tools
- Coaching and mentoring programs

**Clinical Application**: Use database findings to support accommodation recommendation letters and discussions with occupational health providers.

---

## Limitations and Disclaimers

### Critical Limitations

```
+------------------------------------------------------------------+
|                    IMPORTANT LIMITATIONS                           |
+------------------------------------------------------------------+
|                                                                    |
|   THIS DATABASE DOES NOT:                                          |
|                                                                    |
|   X  Provide individualized treatment recommendations              |
|   X  Replace comprehensive clinical evaluation                     |
|   X  Serve as a diagnostic tool or decision system                 |
|   X  Account for individual patient contraindications              |
|   X  Include all published ADHD research                           |
|   X  Guarantee currency of all entries                             |
|   X  Replace professional clinical judgment                        |
|                                                                    |
+------------------------------------------------------------------+
```

### Evidence Limitations

- **Publication bias**: Published studies may overrepresent positive findings
- **Population generalizability**: Studies may not represent all patients
- **Outcome measure variability**: Different studies use different measures
- **Temporal limitations**: Research may not reflect current practice
- **Commercial influence**: Some research is industry-funded

### Database Limitations

- **Curation scope**: Focused on professional adult population
- **Update frequency**: May not include most recent publications
- **Language bias**: Primarily English-language sources
- **Regional variation**: May not reflect all healthcare systems

### Disclaimer Statement

```
+------------------------------------------------------------------+
|                         DISCLAIMER                                 |
+------------------------------------------------------------------+
|                                                                    |
|  The ADHD Research Database is provided for educational and        |
|  clinical reference purposes only. It does not constitute          |
|  medical advice, diagnosis, or treatment recommendations.          |
|                                                                    |
|  Healthcare providers must exercise independent clinical           |
|  judgment when using database information. Treatment decisions     |
|  should be based on comprehensive patient evaluation,              |
|  individual patient factors, and professional expertise.           |
|                                                                    |
|  The database developers and maintainers are not liable for        |
|  clinical decisions made using this resource.                      |
|                                                                    |
+------------------------------------------------------------------+
```

---

## Referral Resources

### When to Refer to Specialists

| Situation | Recommended Referral |
|-----------|---------------------|
| Diagnostic uncertainty | ADHD specialist, neuropsychologist |
| Complex comorbidities | Psychiatrist with ADHD expertise |
| Treatment resistance | ADHD specialist, academic center |
| Medication management complexity | Psychiatrist |
| Significant functional impairment | ADHD coach, occupational therapist |
| Psychological treatment | Psychologist with ADHD expertise |
| Workplace accommodation needs | Occupational health specialist |

### Professional Organizations

**Clinical Resources:**
- American Professional Society of ADHD and Related Disorders (APSARD)
- CHADD Professional Advisory Board
- American Academy of Child and Adolescent Psychiatry (adult ADHD resources)
- American Psychological Association Division 40

**Patient Resources to Recommend:**
- CHADD (Children and Adults with ADHD): chadd.org
- ADDA (Attention Deficit Disorder Association): add.org
- ADDitude Magazine: additudemag.com

### Continuing Education

Healthcare providers treating adult ADHD should consider:
- APSARD annual conference
- CHADD professional training programs
- APA and AMA continuing education modules on adult ADHD
- University-based ADHD clinic training programs

---

## Professional Responsibility Notes

### Standards of Care

When using database resources, maintain adherence to:

- Applicable clinical practice guidelines (APA, NICE, CADDRA)
- Professional licensing board requirements
- Institutional policies and protocols
- Evidence-based medicine principles

### Ethical Considerations

| Principle | Application |
|-----------|-------------|
| **Beneficence** | Use evidence to maximize patient benefit |
| **Non-maleficence** | Acknowledge evidence limitations to avoid harm |
| **Autonomy** | Share evidence to support informed decisions |
| **Justice** | Apply evidence equitably across patient populations |

### Documentation Requirements

Maintain appropriate documentation when using database resources:

- Source of evidence cited in treatment decisions
- Evidence level and quality indicators
- Clinical reasoning for treatment selection
- Patient participation in shared decision-making
- Monitoring plan and outcome measures

### Competency Maintenance

Healthcare providers should:

- Stay current with ADHD research literature
- Participate in continuing education on adult ADHD
- Recognize limits of competence and refer appropriately
- Critically evaluate evidence quality, not just conclusions

---

## Summary

### Key Clinical Takeaways

1. **Evidence hierarchy matters**: Prioritize Level 1A-1B evidence for treatment decisions; use lower levels to supplement clinical judgment.

2. **Screening is not diagnosis**: ASRS and AAQoL support clinical assessment but do not replace comprehensive evaluation.

3. **Quality indicators guide confidence**: Use risk of bias, GRADE ratings, and effect sizes to calibrate clinical confidence.

4. **Workplace context is critical**: Professional adults may have unique presentations and treatment priorities related to occupational functioning.

5. **Shared decision-making**: Use database evidence to inform, not replace, collaborative treatment planning with patients.

6. **Limitations require humility**: Recognize what the database can and cannot provide, and supplement with clinical expertise.

### Quick Reference

| Resource | Purpose | Where to Find |
|----------|---------|---------------|
| Research Explorer | Search evidence | Main database interface |
| ASRS scoring | Symptom screening | Assessment tools section |
| AAQoL interpretation | Functional impact | Assessment tools section |
| Evidence levels | Evaluate research quality | Glossary, this guide |
| Treatment categories | Organize interventions | Intervention library |

### Integration Checklist

Before using database findings in clinical practice:

- [ ] Verified evidence level of cited research
- [ ] Assessed risk of bias or GRADE rating
- [ ] Considered effect size clinical significance
- [ ] Evaluated population comparability to patient
- [ ] Integrated patient preferences and factors
- [ ] Documented evidence-based rationale
- [ ] Established appropriate monitoring plan

---

## Frequently Asked Questions

**Q: Can I use database screening tools to diagnose ADHD?**
A: No. The ASRS and AAQoL are screening and monitoring instruments. Diagnosis requires comprehensive clinical evaluation including clinical interview, developmental history, and differential diagnosis.

**Q: How current is the research in the database?**
A: The database is periodically updated. Check publication dates on individual entries. For the most recent research, supplement database searches with current literature reviews.

**Q: Can I share database printouts with patients?**
A: Yes, with appropriate context. Explain evidence levels and limitations. Database information should supplement, not replace, clinical discussion.

**Q: How do I cite database evidence in medical records?**
A: Include the study reference, evidence level, and key findings. Example: "Per Smith et al. (2023), Level 1B RCT, methylphenidate showed d=0.85 effect on workplace productivity."

**Q: What if database evidence conflicts with my clinical experience?**
A: Clinical expertise is a valid component of evidence-based practice. Document your reasoning when deviating from database evidence, considering patient-specific factors and clinical context.

---

*This clinical use guide is provided for healthcare professional reference only. It does not constitute medical advice or replace professional clinical judgment. Always evaluate individual patient factors and apply evidence within the context of comprehensive clinical care.*

---

**Attribution**: This documentation is part of the ADHD Research Database project. Evidence level framework adapted from Oxford Centre for Evidence-Based Medicine (OCEBM). GRADE methodology from the GRADE Working Group. Assessment information based on published validation studies for ASRS (Kessler et al., 2005; Ustun et al., 2017) and AAQoL (Brod et al., 2006).

**Last Updated**: 2026-02-02
